patiromer 8400 MG Powder for Oral Suspension
- RxCUI
- 1716209
- RxNorm name
- patiromer 8400 MG Powder for Oral Suspension
- Display name
- patiromer 8400 MG Powder for Oral Suspension
- Full name
- patiromer 8400 MG Powder for Oral Suspension
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:19
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VELTASSA | PATIROMER | Vifor Pharma, Inc. | bf002984-d6c9-46df-aecb-a07733f763c1 | 2025-01-31 | Warnings, Adverse reactions | 1716209 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| bf002984-d6c9-46df-aecb-a07733f763c1 | patiromer 8.4 GM Powder for Oral Suspension [PSN] · patiromer 8400 MG Powder for Oral Suspension [SCD] · patiromer 8.4 GM Powder for Oral Suspension [SY] | 3 | 23 | These highlights do not include all the information needed to use VELTASSA ® safely and effectively. See full prescribing information for VELTASSA. VELTASSA (patiromer) for oral suspension Initial U.S. Approval: 2015 | 20250131 |